Mutant and wild-type isocitrate dehydrogenase 1 share enhancing mechanisms involving distinct tyrosine kinase cascades in cancer

Isocitrate dehydrogenase 1 (IDH1) is important for reductive carboxylation in cancer cells, and IDH1 R132H mutant plays a pathogenic role in cancers including acute myeloid leukemia (AML). However, the regulatory mechanisms modulating IDH1 mutant and/or wild-type (WT) function remain unknown. Here w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Discov
Main Authors: Chen, Dong, Xia, Siyuan, Wang, Mei, Lin, Ruiting, Li, Yuancheng, Mao, Hui, Aguiar, Mike, Famulare, Christopher A., Shih, Alan H., Brennan, Cameron W., Gao, Xue, Pan, Yaozhu, Liu, Shuangping, Fan, Jun, Jin, Lingtao, Song, Lina, Zhou, An, Mukherjee, Joydeep, Pieper, Russell O., Mishra, Ashutosh, Peng, Junmin, Arellano, Martha, Blum, William G., Lonial, Sagar, Boggon, Titus J., Levine, Ross L., Chen, Jing
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6548588/
https://ncbi.nlm.nih.gov/pubmed/30862724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-18-1040
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados